| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| Capsule Endoscopy Systems Market Size 2023 |
USD 460.23 million |
| Capsule Endoscopy Systems market, CAGR |
7.96% |
| Capsule Endoscopy Systems Market Size 2032 |
USD 690.23 million |
Market Overview:
The Capsule Endoscopy Systems market is projected to experience substantial growth, with its value expected to increase from USD 460.23 million in 2023 to USD 690.23 million by 2032. This represents a robust Compound Annual Growth Rate (CAGR) of 7.96%.
This significant growth is primarily driven by the escalating prevalence of gastrointestinal (GI) disorders globally. Conditions such as inflammatory bowel disease (IBD) and gastrointestinal bleeding require minimally invasive diagnostic procedures. Capsule endoscopy, known for its patient-friendly approach, provides a range of minimally invasive treatment options for these conditions, contributing to the market’s expansion.
Continuous advancements in capsule endoscope technology are further propelling the market growth. These advancements include improvements in various aspects of the technology such as camera resolution, battery life, capsule size, and wireless transmission capabilities. These enhancements are broadening the scope of applications for capsule endoscopy, making it a more versatile tool in the medical field.
Increased awareness among healthcare professionals and patients about the benefits of capsule endoscopy compared to traditional methods is driving its wider adoption. The aging population worldwide is also contributing to the market expansion. As the incidence of GI disorders is expected to rise with age, the demand for capsule endoscopy procedures is also increasing.
Emerging trends in the market include the integration of artificial intelligence (AI) for image analysis, exploration of capsule endoscopy for non-GI applications, and integration with telemedicine platforms. These trends are reshaping the landscape of capsule endoscopy systems and offer new opportunities for market growth and innovation.
Manufacturers focusing on developing AI-powered systems, expanding into emerging markets, and investing in telemedicine integration stand to capitalize on these opportunities. This focus is expected to further drive the growth of the capsule endoscopy systems market. Thus, the capsule endoscopy systems market is poised for significant growth in the coming years, offering numerous opportunities for stakeholders in the industry.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Drivers:
Rising Prevalence of Gastrointestinal Disorders:
The increasing global incidence of gastrointestinal (GI) disorders, such as inflammatory bowel disease (IBD), Crohn’s disease, ulcerative colitis, and colorectal cancer, is a significant driver for the adoption of capsule endoscopy. For instance, in India, the overall prevalence of self-reported gastrointestinal problems was found to be 18%, with significant variations among regions. In the United States, these conditions account for 105 million ambulatory care visits, 14 million hospital admissions, 236,000 deaths, and $142 billion in total costs annually. With growing awareness of these conditions and an aging population more susceptible to them, there’s a heightened demand for advanced diagnostic tools.
Minimally Invasive Advantages:
Capsule endoscopy provides a minimally invasive alternative to traditional GI endoscopy procedures like colonoscopy and upper endoscopy. This approach offers several advantages for patients, including reduced discomfort, faster recovery times, and a lower risk of complications. For example, a systematic review of 227 studies found that capsule endoscopy had a pooled detection rate of 59.4% for small bowel bleeding, with a low rate of capsule retention (0.75%). Another study reported that capsule endoscopy had a diagnostic yield of 66.6% for iron deficiency anemia, compared to 26.7% for push enteroscopy. Such benefits are increasingly sought after by patients and healthcare providers, driving the adoption of capsule endoscopy as a preferred diagnostic method.
Technological Advancements:
Continuous innovation in capsule endoscopy technology is enhancing its diagnostic capabilities. Manufacturers are improving capsule design, image quality, battery life, and wireless transmission capabilities, resulting in better diagnostic accuracy and efficiency. According to a recent study, the diagnostic yield of capsule endoscopy was 71.4% compared to 28.6% for conventional endoscopy. High-resolution capsule cameras with wider viewing angles and improved illumination enable detailed visualization of the GI tract, contributing to enhanced diagnostic outcomes. For example, the Kvasir-Capsule dataset, a large collection of capsule endoscopy videos, contains images of 14 different classes of GI lesions, with a bounding box around each finding. This dataset can help develop better algorithms for lesion detection and classification. Furthermore, capsule endoscopy technology is evolving to include features such as magnetic steering, active locomotion, drug delivery, and biopsy. These features can increase the control, functionality, and therapeutic potential of capsule endoscopy, making it a more versatile and reliable tool for GI diagnosis and treatment.
Improved Accessibility and Expanding Applications:
Advancements in capsule technology are also improving accessibility and ease of use. Capsule endoscopy procedures can often be performed on an outpatient basis, eliminating the need for hospitalization and making it suitable for a wider range of patients. According to a retrospective study of 131 inpatients who underwent capsule endoscopy, the completion rate was 77.1%, which is comparable to outpatient studies . Moreover, expanding applications beyond the small intestine to areas like the esophagus and colon are broadening the utility of capsule endoscopy, further driving its adoption in clinical practice. For instance, magnetic assisted capsule endoscopy, which allows the examiner to control the capsule movement and position, has shown promising results in detecting gastric lesions with high sensitivity and specificity . Capsule endoscopy is also recommended as the first-line test for obscure gastrointestinal bleeding, with a pooled detection rate of 59.4% in a systematic review of 227 studies .
Growing Reimbursement Coverage and Focus on Early Diagnosis:
As reimbursement policies evolve and the diagnostic efficacy of capsule endoscopy becomes increasingly recognized, healthcare providers are more likely to offer these procedures, making them more accessible to patients. For example, Medicare covers capsule endoscopy for patients with obscure GI bleeding, Crohn’s disease, and celiac disease, as well as for patients who had an incomplete colonoscopy. According to a systematic review, the diagnostic yield of capsule endoscopy for obscure GI bleeding ranges from 38% to 76%, and for Crohn’s disease from 50% to 88%. Additionally, the medical community’s focus on early diagnosis of GI disorders emphasizes the importance of tools like capsule endoscopy, which enable visualization of inaccessible areas and facilitate prompt treatment intervention, ultimately improving patient outcomes. A meta-analysis showed that capsule endoscopy can detect small-bowel tumors with a sensitivity of 89% and a specificity of 95%, and that early detection can improve the survival rate of patients. Capsule endoscopy can also reduce the need for invasive procedures, such as enteroscopy or surgery, which can have higher risks of complications and costs.
Market Trends:
Rising Demand for Minimally Invasive Procedures:
Patients are increasingly seeking minimally invasive diagnostic procedures due to their advantages like faster recovery times, reduced pain, and minimal scarring. For instance, in 2019, there were 18.1 million cosmetic procedures performed in the United States, 16.3 million of which were minimally invasive.
Technological Advancements and Improved Functionality:
Manufacturers are constantly innovating capsule endoscopy technology. Advancements include improved image quality with higher resolution cameras, extended battery life allowing for longer examinations, and capsule designs facilitating better navigation through the digestive tract. These advancements enhance diagnostic accuracy and expand the applications of capsule endoscopy. For instance, in January 2024, AnX Robotica’s artificial intelligence (AI)-integrated reading tool received the United States Food and Drug Administration (FDA) clearance to assist in small bowel capsule endoscopy. This tool can automatically detect and highlight abnormalities in the images captured by the capsule, reducing the reading time and improving the diagnosis efficiency.
Growing Prevalence of Gastrointestinal Disorders:
The global incidence of gastrointestinal disorders like inflammatory bowel disease (IBD) and colorectal cancer is on the rise. For instance, in 2019, there were 7.32 billion incidents and 2.86 billion prevalent cases of digestive diseases, resulting in 8 million deaths and 277 million disability-adjusted life years (DALYs) lost. IBD-related colorectal cancer (CRC) is responsible for 2% of the annual mortality from CRC overall, but 10-15% of the annual deaths in IBD patients. This fuels the demand for capsule endoscopy, as it provides a valuable tool for early diagnosis and treatment planning of these conditions, particularly in hard-to-reach areas of the small intestine. The increasing prevalence of gastrointestinal disorders (GI), cancer, and other chronic ailments has increased the demand for minimally invasive procedures thereby increasing the adoption of capsule endoscopes.
Increasing Awareness and Expanding Applications:
The growing awareness among healthcare professionals and the public about the benefits of capsule endoscopy is leading to its wider adoption. Additionally, the development of capsule endoscopy for examining other areas of the digestive tract beyond the small intestine, such as the esophagus, offers promising future applications. This expansion is supported by the rising prevalence of gastrointestinal disorders and the demand for minimally invasive diagnostic procedures. For instance, the detection rate (DR) for small bowel capsule endoscopy stands at 59%, with a completion rate (CR) of 89.6% and a retention rate (RR) of only 2%, indicating high efficacy and safety. These factors collectively contribute to the expanding market potential of capsule endoscopy.
Market Restraints and Challenges:
High Cost of Procedures:
Capsule endoscopy procedures are significantly more expensive compared to traditional endoscopy methods. This cost encompasses factors like the capsule itself, disposable components, physician fees, and facility charges. This high cost can be a significant barrier for patients, particularly those with limited insurance coverage. Manufacturers are working on reducing production costs, but affordability remains a hurdle for wider adoption.
Limited Reimbursement Policies:
Reimbursement policies for capsule endoscopy procedures vary widely across healthcare systems. In some regions, coverage for capsule endoscopy is limited or non-existent, discouraging patients from opting for this diagnostic approach. Advocacy efforts are needed to educate healthcare providers and policymakers about the benefits of capsule endoscopy to promote broader insurance coverage and facilitate patient access.
Technical Limitations and Image Quality:
While capsule endoscopy offers a valuable minimally invasive approach, it has technical limitations compared to traditional endoscopy. Capsule endoscopy systems lack the ability to perform biopsies or therapeutic interventions during the procedure. Additionally, image quality can be compromised by factors like capsule movement, intestinal contents, and bowel folds. Advancements in capsule technology and image processing are underway to address these limitations and improve visualization capabilities.
Need for Specialized Training:
Effective utilization of capsule endoscopy systems requires specialized training for healthcare professionals. This includes expertise in interpreting the capsule images and navigating the complexities of the procedure. The limited availability of trained personnel, particularly in remote areas, can restrict access to this diagnostic tool for patients. Expanding training programs for physicians and technicians is crucial to overcome this challenge.
Data Security and Privacy Concerns:
As capsule endoscopy generates significant amounts of patient data, ensuring data security and privacy remains a paramount concern. Cybersecurity threats and the potential for misuse of sensitive patient information necessitate robust data management protocols and adherence to privacy regulations. Manufacturers and healthcare providers need to collaborate on implementing strong data security measures and patient privacy protocols to build trust and encourage wider adoption of capsule endoscopy systems.
Recent Developments:
- Robotic Wireless Capsule Endoscopy(January 2024): Researchers have made strides in developing robotic wireless capsule endoscopy (WCE) devices that can autonomously navigate and perform therapeutic interventions within the gastrointestinal tract. These advancements aim to address the limitations of traditional capsule endoscopes, particularly in lesion detection and treatment capabilities. The new designs leverage micro-electromechanical systems (MEMS) and artificial intelligence (AI) for enhanced functionality, including real-time imaging and intelligent lesion detection.
- CapsoCam Plus System Launch(April 2023): CapsoVision introduced its CapsoCam Plus system, which features four cameras providing a 360-degree view of the small intestine. This system enhances visualization of gastrointestinal lesions and abnormalities, marking a significant improvement over traditional capsule endoscopes that typically offer a limited field of view.
- Integration of AI for Lesion Detection(February 2023): The application of AI technologies in capsule endoscopy has gained momentum, with several studies demonstrating the effectiveness of AI in automating the detection of lesions, thereby reducing the time required for manual image analysis. This integration is expected to improve diagnostic accuracy and efficiency in clinical settings.
- Hybrid Imaging Techniques Development(March 2023): Research has focused on developing hybrid imaging techniques that combine capsule endoscopy with advanced optical methods. These techniques aim to enhance the diagnostic capabilities of capsule endoscopes, particularly for detecting neoplastic tissues and other gastrointestinal abnormalities.
- Market Growth Projections(2023): The capsule endoscopy market is projected to grow significantly, this growth is driven by increasing demand for non-invasive diagnostic procedures and advancements in capsule technology.
- Emerging Therapeutic Capabilities(2024): Ongoing research is exploring the potential for capsule endoscopes to perform therapeutic functions, such as the ability to deliver localized treatments directly to lesions identified during the examination. This capability could revolutionize the role of capsule endoscopy in gastrointestinal care
Segmentation Analysis:
By Type:
The market is divided into two types: small bowel capsule endoscopy and colon capsule endoscopy. Small bowel capsule endoscopy is widely used due to its effectiveness in diagnosing small bowel diseases. However, colon capsule endoscopy is gaining popularity due to advancements in technology and its non-invasive nature.
By Technology:
This segment includes wireless and wired capsule endoscopy systems. Wireless systems are leading the market due to their convenience and patient comfort. However, wired systems are also used in certain clinical settings.
By End User:
The market caters to hospitals, clinics, and research centres. Hospitals are the largest end-user segment due to the availability of advanced infrastructure and skilled professionals. However, the use of capsule endoscopy systems in clinics and research centres is also growing due to increased awareness and technological advancements.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Segments:
By Product
By Application
- OGIB (Obscure GI Tract Bleeding)
- Crohn’s Disease
- Small Intestine Tumor
- Others
By End-use
- Hospitals
- Ambulatory Surgery Centers/Clinics
- Other End-uses
By Regional
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Key player:
- Hangxian Minimal Invasive Inc.
- IntroMedic Co.
- MEDTRONIC PLC.
- Fujifilm Holding Corporation
- Olympus Corporation
- Anx Robotica
- Chongqing Jinshan Science and Technology Group Co.
- CapsoVision Inc.
- Check-Cap, RF Systems Lab
- Given Imaging (Medtronic Plc)
- RF System lab
Regional Analysis:
North America:
Currently holding the largest market share, North America is anticipated to maintain its dominance throughout the forecast period. This dominance can be attributed to several factors, including a high prevalence of gastrointestinal (GI) disorders, a well-established healthcare infrastructure, and strong adoption of advanced medical technologies. Additionally, the presence of major market players in the region further propels market growth.
Europe:
Europe follows closely behind North America in terms of market share. The region benefits from a similar focus on advanced medical technologies and a growing geriatric population, both of which contribute to the demand for capsule endoscopy systems. Furthermore, increasing healthcare spending and growing awareness of minimally invasive procedures are expected to drive market expansion in Europe.
Asia Pacific:
The Asia Pacific region is expected to witness the fastest growth rate during the forecast period. This can be ascribed to factors such as rising disposable income, improving healthcare infrastructure, and a growing awareness of GI diseases. Additionally, the presence of a large and aging population susceptible to GI disorders presents a significant market opportunity.
Future Outlook:
- Capsule endoscopy’s capability for examining previously inaccessible areas will lead to its adoption in new diagnostic applications beyond the small intestine.
- Advancements in capsule technology, including improved image quality, longer battery life, and wireless capsule control, will enhance diagnostic capabilities and user experience.
- The increasing incidence of gastrointestinal disorders like inflammatory bowel disease and colorectal cancer will fuel demand for minimally invasive diagnostic tools like capsule endoscopy.
- The expanding geriatric population, susceptible to gastrointestinal issues, will create a larger patient pool for capsule endoscopy procedures.
- The growing preference for minimally invasive procedures, with faster recovery times and reduced patient discomfort, will benefit the capsule endoscopy market.
- Favorable reimbursement policies by healthcare payers for capsule endoscopy procedures will incentivize wider adoption by healthcare institutions.
- Growing disposable income in developing economies will allow more patients to access advanced diagnostic procedures like capsule endoscopy.
- Integration of artificial intelligence (AI) for image analysis and interpretation will improve diagnostic accuracy and efficiency in capsule endoscopy procedures.
- Manufacturers will strive to develop cost-effective capsule endoscopy systems, making the technology more accessible to a broader range of healthcare providers.
- Educational campaigns and growing awareness among healthcare professionals and patients regarding the benefits of capsule endoscopy will drive market expansion.
